Visits: 2828, Avg visit time (secs): 226,25 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1378 | 48,73% | |
| /amylin/efsd-amylin-rfa09.html | 350 | 12,38% |
| /programmes.html | 306 | 10,82% |
| /home.html | 173 | 6,12% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa09.html | 54 | 1,91% |
| /msd/albert-renold/efsd-msd-arenold.html | 50 | 1,77% |
| /novo-t2/efsd-novo-t2-rfa09.html | 45 | 1,59% |
| /amylin/efsd-amylin-rfa10.html | 40 | 1,41% |
| /lilly/programme/efsd-lilly-rfa09.html | 33 | 1,17% |
| /regulations.html | 33 | 1,17% |
| /roche/efsd-roche-rfa09.html | 30 | 1,06% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1446 | 51,13% |
| /programmes.html | 292 | 10,33% |
| /lifescan/efsd-lifescan-rfa09.html | 263 | 9,30% |
| /novo-t2/efsd-novo-t2-rfa09.html | 125 | 4,42% |
| /lilly/programme/efsd-lilly-rfa09.html | 112 | 3,96% |
| /home.html | 80 | 2,83% |
| /recipients.html | 58 | 2,05% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa09.html | 54 | 1,91% |
| /msd/albert-renold/efsd-msd-arenold.html | 46 | 1,63% |
| /reviewers.html | 20 | 0,71% |
| /gsk/efsd-gsk-rfa09.html | 19 | 0,67% |